MA
LKFT

Montag & Associates’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Montag & Associates’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6
Closed -$208 – 1042
2025
Q3 		$208 Buy
+6
New +$192 ﹤0.01% 1114

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Montag & Associates's LKFT Position: Q4 2025 in Review

Montag & Associates sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2025, closing a stake of 6 shares — an estimated $208 sold.

Montag & Associates first reported a position in LKFT in Q3 2025 and held it in 1 quarter. The position peaked at $208 in Q3 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q4 2025.

  • Montag & Associates reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2025 after selling out during the quarter.
  • Montag & Associates sold 6 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2025, an estimated $208.
  • Montag & Associates first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2025 and held it in 1 quarter.
  • Montag & Associates's Lakefront Biotherapeutics American Depositary Shares position peaked at $208 in Q3 2025.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2025.

Based on Montag & Associates's 13F filing for Q4 2025, filed 2 Feb 2026.